don't worry if you don't have an account with us, we'll create one
[{"meta":{"author":"Breast Cancer Latest Developments Reviewed by Prof Zielinski","authorlink":""},"src":"https:\/\/itunesu-assets.itunes.apple.com\/itunes-assets\/CobaltPublic4\/v4\/f7\/78\/b5\/f778b55e-e059-c5d0-e237-844e0a732be2\/2349d5bc9602baefb8e945c2a3babc451c89e5eb57a680c4d11032ed89ef24d5-22314066446.mp4?a=v=3&artistId=1280772961&podcastId=608999191&podcastNam","thumb":{"src":"https:\/\/images.lystnfm.com\/tr:n-app_thumbnail_medium\/podcastsnw-202106\/ec5796-0080-dc62-899506_800.jpg"},"title":"Novel Drug Formulations for Breast Cancer Already Available Out There! - EBCC 2012","link":"javascript:;","id":"item-260258"},{"meta":{"author":"Breast Cancer Latest Developments Reviewed by Prof Zielinski","authorlink":""},"src":"https:\/\/itunesu-assets.itunes.apple.com\/itunes-assets\/CobaltPublic\/v4\/c5\/e0\/f8\/c5e0f8a2-60f9-8198-b0bf-a27268fa2228\/da4618c007a08fdcad1fb6c20780631448216a53cc7445173e99b7702349d699-22315016307.mp4?a=v=3&artistId=1280772961&podcastId=608999191&podcastName","thumb":{"src":"https:\/\/images.lystnfm.com\/tr:n-app_thumbnail_medium\/podcastsnw-202106\/ec5796-0080-dc62-899506_800.jpg"},"title":"Treatment Resistance and Metastasis Development in Breast Cancer - EBCC 2012","link":"javascript:;","id":"item-260257"},{"meta":{"author":"Breast Cancer Latest Developments Reviewed by Prof Zielinski","authorlink":""},"src":"https:\/\/itunesu-assets.itunes.apple.com\/itunes-assets\/CobaltPublic6\/v4\/b5\/da\/6a\/b5da6aa8-85dd-35f6-0f82-c320160e515b\/b0412c053d63ec10857b2b3a2c848356176b49aae66beaf875fdbaa45be5b87d-22314066626.mp4?a=v=3&artistId=1280772961&podcastId=608999191&podcastNam","thumb":{"src":"https:\/\/images.lystnfm.com\/tr:n-app_thumbnail_medium\/podcastsnw-202106\/ec5796-0080-dc62-899506_800.jpg"},"title":"Breast Cancer and Social Issues- EBCC 2012","link":"javascript:;","id":"item-260256"}]